About Caladrius

Caladrius Biosciences, Inc. is a late-stage therapeutics development biopharmaceutical company pioneering advancements of cell therapies in select cardiovascular and autoimmune diseases.

News

February 3, 2020
Caladrius Biosciences to Participate at Upcoming February Conferences

January 7, 2020
Caladrius Biosciences to Participate at Upcoming January Conferences

December 2, 2019
Caladrius Biosciences to Participate at Upcoming December Conferences

Events

February 18, 2020
Noble Capital Markets’ 16th Annual Investor Conference

November 6, 2019
Caladrius Biosciences 3rd Quarter 2019 Financial Results and Business Update Conference Call

September 10, 2019
21st Annual Global Investment Conference, Sponsored by H.C. Wainwright

Sign up to our e-mail list to receive Caladrius announcements.

Technologies & Capabilities

T Regulatory Cell Technology

CD34 Cell Technology